BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 6123594)

  • 1. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of K-opiate sites by dynorphin in the myenteric plexus.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Loh HH; Way EL
    Adv Biochem Psychopharmacol; 1982; 33():91-8. PubMed ID: 6127009
    [No Abstract]   [Full Text] [Related]  

  • 3. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin-(1-13) restores the potency of morphine on the tolerant guinea pig ileum.
    Rezvani A; Way EL
    Eur J Pharmacol; 1984 Jul; 102(3-4):475-9. PubMed ID: 6149134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin interaction at the kappa-opiate site.
    Huidobro-Toro JP; Yoshimura K; Lee NM; Loh HH; Way EL
    Eur J Pharmacol; 1981 Jun; 72(2-3):265-6. PubMed ID: 6113976
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 8. Opioid receptor selectivity of dynorphin gene products.
    James IF; Fischli W; Goldstein A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):88-93. PubMed ID: 6141278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple opiate receptors for multiple opioid peptides.
    Miller RJ
    Med Biol; 1982 Feb; 60(1):1-6. PubMed ID: 6121959
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The choice of opioid receptor subtype in isolated preparations by dynorphins.
    Oka T; Aoki K; Kajiwara M
    Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage dependent changes in opiate inhibition of electrically-driven guinea pig ileum longitudinal muscle.
    Matos FF; Malone MH
    Proc West Pharmacol Soc; 1985; 28():151-2. PubMed ID: 2999807
    [No Abstract]   [Full Text] [Related]  

  • 14. A characterization of dynorphin-(1-13) on the guinea pig ileal longitudinal muscle.
    Vaught JL
    Eur J Pharmacol; 1981 Dec; 76(4):453-6. PubMed ID: 6276199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible modulatory role of dynorphin on the excitation by neurotensin on the guinea pig myenteric plexus.
    Huidobro-Toro JP; Way EL
    Neurosci Lett; 1982 Jun; 30(3):309-14. PubMed ID: 7110637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental kappa binding site : interaction with dynorphin and its possible implication in hCG secretion.
    Valette A; Tafani M; Porthe G; Pontonnier G; Cros J
    Life Sci; 1983; 33 Suppl 1():523-6. PubMed ID: 6141498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum.
    Yoshimura K; Huidobro-Toro JP; Way EL
    Eur J Pharmacol; 1982 Oct; 84(1-2):17-24. PubMed ID: 6128236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal responses of guinea-pig isolated ileum following brief exposure to opiates and opioid peptides.
    Chahl LA
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):387-92. PubMed ID: 2430191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
    Koike K; Takayanagi I; Hirakura Y; Matsueda R
    Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.